• US Stocks
  • AstraZeneca PLC
AstraZeneca PLC

AstraZeneca PLC

Large Cap 
  • $ 66.57

    Stock Price

  • -$ 0.42(-0.63%)

    Last Change

About the company

AstraZeneca PLC

AstraZeneca PLC engages in the discovery, development, manufacture, and commercialization of prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; strategic collaboration with FibroGen and Astellas; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
View More
    Total Revenue
    $ 10.771 B
    Cost of Revenue
    $ 2.998 B
    Gross Profit
    $ 7.773 B
    Operating Income
    $ 417.000 M
Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 67.36

1D High

$ 66.55

1D Low

-$ 0.42 (-0.63%)

1D Change

Last updated on 

Previous Close
$ 66.99
Open Price
$ 66.73
52 Week High
$ 71.09
52 Week Low
$ 51.90
PE Ratio
Avg. Volume
Market Cap
$ 206.343 B


Stock NameStock Price52 Week High52 Week LowCapital
Novartis AG
Novartis AG
$ 94.04$ 105.61$ 78.81Large Cap
$ 98.46$ 122.66$ 92.83Large Cap
$ 155.56$ 181.77$ 151.23Large Cap
$ 56.28$ 78.63$ 55.70Large Cap
$ 103.35$ 118.05$ 94.42Large Cap
$ 39.75$ 43.84$ 32.35Large Cap
$ 261.22$ 311.88$ 187.16Large Cap
$ 48.79$ 56.20$ 36.91Large Cap
$ 32.34$ 53.25$ 31.77Large Cap
$ 726.02$ 800.78$ 367.60Large Cap

Frequently Asked Questions

What is the price of AstraZeneca PLC share today in India?

Today, on 20th Apr 2024, the price of AstraZeneca PLC Shares in India is $ 66.57.

What was the highest AstraZeneca PLC share stock price?

The highest AstraZeneca PLC stock price was $ 71.09 till 20th Apr 2024 within the past 52 weeks.

What is the lowest price of AZN shares?

The lowest AZN stock price was $ 51.9 on 20th Apr 2024 within the past 52 weeks.

How to buy AZN shares in India?

You can buy AZN shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is AstraZeneca PLC shares Listed on NSE or BSE?

No, AZN shares are not listed on NSE or BSE. AstraZeneca PLC is listed on the NASDAQ stock exchange.

Can I buy AstraZeneca PLC shares in India?

Yes, you can buy AstraZeneca PLC shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of AstraZeneca PLC?

Yes, you can buy fractional shares of AstraZeneca PLC with Scripbox.

What is the P/E ratio for AstraZeneca PLC shares?

As on 20th Apr 2024, the P/E ratio for AstraZeneca PLC shares is 63.4.

What is the traded volume of AstraZeneca PLC shares?

As on 20th Apr 2024, the traded volume for AstraZeneca PLC shares is 4.168 M.

What is the market capitalization of AstraZeneca PLC shares?

AstraZeneca PLC shares has a market capitalization of $ 206.343 B.